{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"MLH1, a tumor suppressor involved in DNA mismatch repair, is recurrently altered by deletion and mutation in various cancer types. Germline mutations of MLH1 are associated with Lynch syndrome and predispose to colorectal cancer.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"01/11/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "21120944",
        "18383312"
      ]
    },
    "description":"The MLH1 G67R mutation is located in the HATPase domain of the protein. This mutation has been found in a proband associated with microsatellite instability (MSI) (PMID: 18383312). In silico analysis and in vitro assays demonstrate that MLH1 G67R is inactivating as measured by reduced mismatch repair activity compared to wildtype (PMID: 21120944, 18383312).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"G67R",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":4292,
    "hgvs":"3:g.36996701G>A",
    "hugoSymbol":"MLH1",
    "id":null,
    "proteinEnd":67,
    "proteinStart":67,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The MLH1 G67R mutation is likely oncogenic.",
  "vus":false
}